uniQure
QURE
#5397
Rank
S$1.75 B
Marketcap
S$28.15
Share price
1.71%
Change (1 day)
187.50%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2025 (TTM): -S$0.3 Billion

According to uniQure's latest financial reports the company's current earnings are S$15.75 Million. In 2024 the company made an earning of -S$0.31 Billion, an increase over its 2023 earnings that were of -S$0.4 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.3 Billion-3.62%
2024 -S$0.31 Billion-22.65%
2023 -S$0.4 Billion139.01%
2022 -S$0.17 Billion-138.54%
2021 S$0.43 B-335.29%
2020 -S$0.19 Billion13.88%
2019 -S$0.17 Billion49.51%
2018 -S$0.11 Billion4.55%
2017 -S$0.11 Billion12.65%
2016 -S$91.52 Million-9.59%
2015 -S$0.11 Billion66.95%
2014 -S$60.63 Million30.8%
2013 -S$46.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$10.69 B-3,768.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-S$0.15 Billion-51.49%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-S$0.26 Billion-11.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
-S$0.72 Billion 144.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.80 B-4,149.19%๐Ÿ‡ซ๐Ÿ‡ท France
BioMarin Pharmaceutical
BMRN
S$0.88 B-402.24%๐Ÿ‡บ๐Ÿ‡ธ USA